Rigel Pharmaceuticals (RIGL) Capital Expenditures Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 143.40% |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -146.15% |
| Dec 31, 2022 | 447.62% |
| Sep 30, 2022 | 11.18% |
| Jun 30, 2022 | -108.85% |
| Mar 31, 2022 | 215.49% |
| Dec 31, 2021 | -104.17% |
| Sep 30, 2021 | -12.82% |
| Jun 30, 2021 | 1,025.00% |
| Mar 31, 2021 | -88.30% |
| Dec 31, 2020 | -17.51% |
| Sep 30, 2020 | -44.60% |
| Jun 30, 2020 | -138.26% |
| Mar 31, 2020 | 61.01% |
| Dec 31, 2019 | 785.51% |
| Sep 30, 2019 | 125.64% |
| Jun 30, 2019 | -83.19% |
| Mar 31, 2019 | 91.37% |
| Dec 31, 2018 | 30.19% |
| Sep 30, 2018 | 178.57% |
| Jun 30, 2018 | 4,785.71% |
| Mar 31, 2018 | 380.49% |
| Dec 31, 2017 | 783.33% |
| Sep 30, 2017 | -77.78% |
| Jun 30, 2017 | -93.78% |
| Mar 31, 2017 | -87.23% |
| Dec 31, 2016 | -95.52% |
| Sep 30, 2016 | -17.92% |
| Jun 30, 2016 | 208.22% |
| Mar 31, 2016 | 903.13% |
| Dec 31, 2015 | -33.00% |
| Sep 30, 2015 | 867.50% |
| Jun 30, 2015 | -2.67% |
| Mar 31, 2015 | -82.02% |
| Dec 31, 2014 | 19.05% |
| Sep 30, 2014 | -131.25% |
| Jun 30, 2014 | -69.88% |
| Mar 31, 2014 | -73.67% |
| Dec 31, 2013 | -72.05% |
| Sep 30, 2013 | -66.67% |
| Jun 30, 2013 | -69.56% |
| Mar 31, 2013 | -57.05% |
| Dec 31, 2012 | 224.86% |
| Sep 30, 2012 | -31.55% |
| Jun 30, 2012 | 17.36% |
| Mar 31, 2012 | 83.02% |
| Dec 31, 2011 | -80.06% |
| Sep 30, 2011 | -37.46% |